<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-11-03 11:26:18Medicine Intel Viiv Integrase ViiV Healthcare Shionogi New Drug Application HIV Food and Drug Administration Dolutegravir Integrase inhibitors Pharmaceutical sciences Biology |
| Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmaceDocID: 1uvYN - View Document |
| Emergency Use: means the use of a test article on a human subject in a life-threatening situation inDocID: 1riMu - View Document |
| United States Government Accountability Office GAO Report to the Ranking Member, Committee on Finance, U.S. SenateDocID: 1riEa - View Document |
| Microsoft Word - FINAL 10K2014-Cover Page final to printDocID: 1r76P - View Document |
| Clark Transfer, Inc. Owner-Operator Application IMPORTANT NOTICE REGARDING BACKGROUND REPORTSDocID: 1qZGZ - View Document |